Kansas Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 6.06 M
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.73 Cr
About Kansas Laboratories
Kansas Laboratories Pvt Ltd (KLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 November 1986 and has a history of 38 years and three months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.06 M.
The company has closed loans amounting to ₹1.73 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anil Shah, Dipak Shah, Neerav Shah, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U27109WB1986PTC041462
-
Company No.
041462
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Nov 1986
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Kansas Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Shah
|
Director | 03-Nov-1986 | Current |
|
Dipak Shah
|
Director | 03-Nov-1986 | Current |
|
Neerav Shah
|
Director | 14-Sep-2023 | Current |
|
Subir Dutta
|
Director | 15-May-2024 | Current |
Financial Performance of Kansas Laboratories.
Kansas Laboratories Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kansas Laboratories?
In 2017, Kansas Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kansas Drugs & Pharmaceuticals Pvt.Ltd.Anil Shah, Dipak Shah and 1 more are mutual person
Charges (Loans)
₹0
₹17.30 M
Charges Breakdown by Lending Institutions
- Canara Bank : 1.73 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2006 | Canara Bank | ₹1.73 Cr | Satisfied |
How Many Employees Work at Kansas Laboratories?
Kansas Laboratories has a workforce of 62 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kansas Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kansas Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
